SCHEMBL6409843

SCHEMBL6409843

O=C(NCc1ccccc1)OC1=NOC2(CCN(C(=O)c3ccncc3)CC2)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.47
CYP2D6 P10635 5/20 0.47
TSHR P16473 4/20 0.47
CYP2C19 P33261 4/20 0.47
NAMPT P43490 5/20 0.44
CCR8 P51685 1/20 0.43
KCNH2 Q12809 1/20 0.43
CYP2C9 P11712 4/20 0.43
BCHE P06276 1/20 0.43
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 2/20 0.41
USP2 O75604 1/20 0.41
EPHX1 P07099 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HIF1A Q16665 1/20 0.40
CA1 P00915 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409864 0.91 KMT2A (0.43) CYP2C19ALDH1A1CYP1A2KMT2A
SCHEMBL6410565 0.89 CYP2D6 (0.51) CYP3A4CYP2D6TSHRCYP2C19CYP2C9
SCHEMBL6410103 0.86 CYP2D6 (0.42) CYP2D6BCHEALDH1A1MEN1KMT2A
SCHEMBL6409746 0.86 NAMPT (0.47) CYP3A4TSHRNAMPTCYP2C9ALDH1A1
SCHEMBL6409695 0.84 HTR1A (0.49)
SCHEMBL6410288 0.83 NAMPT (0.41) CYP3A4CYP2D6TSHRCYP2C19NAMPT
SCHEMBL6409707 0.83 MAPK8 (0.51) CYP3A4CYP2C19CYP2C9ALDH1A1
SCHEMBL2400949 0.83 CYP3A4 (0.50) CYP3A4CYP2D6TSHRCYP2C19NAMPT
SCHEMBL6409721 0.82 CYP2D6 (0.36) CYP3A4CYP2D6TSHRCYP2C19ALDH1A1
SCHEMBL6410188 0.82 MEN1 (0.45) CYP2D6TSHRCYP2C19ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed